NO20084631L - Fremgangsmate for dannelsen av pyrazolylaminoquinazolin deivater inneholdende en fosfat gruppe - Google Patents
Fremgangsmate for dannelsen av pyrazolylaminoquinazolin deivater inneholdende en fosfat gruppeInfo
- Publication number
- NO20084631L NO20084631L NO20084631A NO20084631A NO20084631L NO 20084631 L NO20084631 L NO 20084631L NO 20084631 A NO20084631 A NO 20084631A NO 20084631 A NO20084631 A NO 20084631A NO 20084631 L NO20084631 L NO 20084631L
- Authority
- NO
- Norway
- Prior art keywords
- pyrazolylaminoquinazoline
- formation
- phosphate group
- derivatives containing
- amino
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- ZOLMXQVLFGWBPK-UHFFFAOYSA-N n-(1h-pyrazol-5-yl)quinazolin-2-amine Chemical class N=1C=C2C=CC=CC2=NC=1NC=1C=CNN=1 ZOLMXQVLFGWBPK-UHFFFAOYSA-N 0.000 title 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 title 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0609617.6A GB0609617D0 (en) | 2006-05-16 | 2006-05-16 | Process & intermediate |
| PCT/GB2007/001748 WO2007132210A1 (en) | 2006-05-16 | 2007-05-14 | Process for the preparation of pyrazolylaminoquinazoline derivatives comprising a phosphate group |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20084631L true NO20084631L (no) | 2008-12-03 |
Family
ID=36637525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20084631A NO20084631L (no) | 2006-05-16 | 2008-11-04 | Fremgangsmate for dannelsen av pyrazolylaminoquinazolin deivater inneholdende en fosfat gruppe |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8063210B2 (es) |
| EP (1) | EP2019832B1 (es) |
| JP (1) | JP5249927B2 (es) |
| KR (1) | KR101463633B1 (es) |
| CN (1) | CN101443339B (es) |
| AR (1) | AR060962A1 (es) |
| AU (1) | AU2007251395B2 (es) |
| BR (1) | BRPI0712787A2 (es) |
| CA (1) | CA2650518C (es) |
| ES (1) | ES2392996T3 (es) |
| GB (1) | GB0609617D0 (es) |
| HK (1) | HK1126221A1 (es) |
| IL (1) | IL194861A0 (es) |
| MX (1) | MX2008014551A (es) |
| NO (1) | NO20084631L (es) |
| NZ (1) | NZ572204A (es) |
| TW (1) | TWI387601B (es) |
| WO (1) | WO2007132210A1 (es) |
| ZA (1) | ZA200809171B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4498741B2 (ja) * | 2001-12-24 | 2010-07-07 | アストラゼネカ アクチボラグ | オーロラキナーゼ阻害剤としての置換キナゾリン誘導体 |
| CA2526285A1 (en) * | 2003-05-15 | 2004-12-23 | Arqule, Inc. | Inhibitors of p38 and methods of using the same |
| WO2006044869A1 (en) * | 2004-10-19 | 2006-04-27 | Arqule, Inc. | Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| EP2013218A2 (en) * | 2006-04-17 | 2009-01-14 | Arqule, Inc. | Raf inhibitors and their uses |
| AU2009322158A1 (en) * | 2008-12-05 | 2010-06-10 | Arqule, Inc. | RAF inhibitors and their uses |
| CN103664797A (zh) * | 2012-09-25 | 2014-03-26 | 杨子娇 | 一类治疗房角狭窄的化合物及其用途 |
| CN103435598B (zh) * | 2013-07-25 | 2015-08-05 | 苏州明锐医药科技有限公司 | 巴拉塞替的制备方法 |
| PT3311845T (pt) | 2013-09-16 | 2020-04-02 | Astrazeneca Ab | Nanopartículas poliméricas terapêuticas e métodos para fabrico e uso das mesmas |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4498741B2 (ja) | 2001-12-24 | 2010-07-07 | アストラゼネカ アクチボラグ | オーロラキナーゼ阻害剤としての置換キナゾリン誘導体 |
| US7022667B2 (en) * | 2002-07-03 | 2006-04-04 | Bristol-Myers Squibb Company | O-derivatized nocathiacin derivatives |
| DE60315892T2 (de) | 2002-12-24 | 2008-08-14 | Astrazeneca Ab | Phosphonooxy-chinazolin derivate und ihre pharmazeutische verwendung |
| WO2004058752A1 (en) | 2002-12-24 | 2004-07-15 | Astrazeneca Ab | Quinazoline compounds |
| CN100349906C (zh) * | 2002-12-24 | 2007-11-21 | 阿斯利康(瑞典)有限公司 | 膦酰氧基喹唑啉衍生物及其药物用途 |
| DE602004012725T2 (de) | 2003-04-16 | 2009-04-16 | Astrazeneca Ab | Quinazolin-derivate für die behandling von krebs |
| ATE401080T1 (de) | 2003-06-02 | 2008-08-15 | Astrazeneca Ab | (3-((chinazolin-4-yl)amino)-1h-pyrazol-1- yl)acetamid derivate und verwandte verbindungen als aurora kinase inhibitoren zur behandlung von proliferativen erkrankungen wie krebs |
| GB0609619D0 (en) * | 2006-05-16 | 2006-06-21 | Astrazeneca Ab | Combination |
-
2006
- 2006-05-16 GB GBGB0609617.6A patent/GB0609617D0/en not_active Ceased
-
2007
- 2007-05-14 CN CN2007800176933A patent/CN101443339B/zh not_active Expired - Fee Related
- 2007-05-14 EP EP07732773A patent/EP2019832B1/en active Active
- 2007-05-14 BR BRPI0712787-1A patent/BRPI0712787A2/pt not_active IP Right Cessation
- 2007-05-14 JP JP2009510529A patent/JP5249927B2/ja not_active Expired - Fee Related
- 2007-05-14 CA CA2650518A patent/CA2650518C/en not_active Expired - Fee Related
- 2007-05-14 KR KR1020087029568A patent/KR101463633B1/ko not_active IP Right Cessation
- 2007-05-14 ES ES07732773T patent/ES2392996T3/es active Active
- 2007-05-14 AU AU2007251395A patent/AU2007251395B2/en not_active Ceased
- 2007-05-14 NZ NZ572204A patent/NZ572204A/en not_active IP Right Cessation
- 2007-05-14 WO PCT/GB2007/001748 patent/WO2007132210A1/en active Application Filing
- 2007-05-14 MX MX2008014551A patent/MX2008014551A/es active IP Right Grant
- 2007-05-15 US US11/748,655 patent/US8063210B2/en not_active Expired - Fee Related
- 2007-05-16 AR ARP070102120A patent/AR060962A1/es unknown
- 2007-05-16 TW TW096117466A patent/TWI387601B/zh not_active IP Right Cessation
-
2008
- 2008-10-23 IL IL194861A patent/IL194861A0/en not_active IP Right Cessation
- 2008-10-24 ZA ZA200809171A patent/ZA200809171B/xx unknown
- 2008-11-04 NO NO20084631A patent/NO20084631L/no unknown
-
2009
- 2009-05-18 HK HK09104518.6A patent/HK1126221A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ572204A (en) | 2011-09-30 |
| CA2650518A1 (en) | 2007-11-22 |
| WO2007132210A1 (en) | 2007-11-22 |
| CN101443339A (zh) | 2009-05-27 |
| TW200813080A (en) | 2008-03-16 |
| EP2019832B1 (en) | 2012-09-12 |
| EP2019832A1 (en) | 2009-02-04 |
| KR101463633B1 (ko) | 2014-11-19 |
| TWI387601B (zh) | 2013-03-01 |
| ZA200809171B (en) | 2009-11-25 |
| KR20090008450A (ko) | 2009-01-21 |
| CA2650518C (en) | 2014-12-02 |
| US20070270384A1 (en) | 2007-11-22 |
| CN101443339B (zh) | 2012-07-04 |
| GB0609617D0 (en) | 2006-06-21 |
| JP5249927B2 (ja) | 2013-07-31 |
| HK1126221A1 (en) | 2009-08-28 |
| MX2008014551A (es) | 2008-11-27 |
| AR060962A1 (es) | 2008-07-23 |
| US8063210B2 (en) | 2011-11-22 |
| BRPI0712787A2 (pt) | 2012-09-11 |
| AU2007251395B2 (en) | 2011-01-06 |
| IL194861A0 (en) | 2009-08-03 |
| AU2007251395A1 (en) | 2007-11-22 |
| JP2009537496A (ja) | 2009-10-29 |
| ES2392996T3 (es) | 2012-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20084631L (no) | Fremgangsmate for dannelsen av pyrazolylaminoquinazolin deivater inneholdende en fosfat gruppe | |
| UA95108C2 (en) | Maleate co-crystal of azd1152 and use thereof for the treatment of cancer | |
| EA200970090A1 (ru) | Модуляторы метаболизма и лечение связанных с ним расстройств | |
| NO20091626L (no) | MGLUR5-modulatorer | |
| CY1119827T1 (el) | Ακυλαμινο-υποκατεστημενα συντηγμενα παραγωγα κυκλοπεντανο καρβοξυλικου οξεος και η χρηση αυτων ως φαρμακευτικων ουσιων | |
| ATE522518T1 (de) | Indazol- und isoindolderivate als glucokinaseaktivierende stoffe | |
| SI2091948T1 (sl) | Novi inhibitorji glutaminil ciklaze | |
| NO20063501L (no) | Kinolinintermediater av reseptor-Tyrosin-Kinase-inhibitorer og deres syntese | |
| EA200970088A1 (ru) | Модуляторы метаболизма и лечение связанных с ним нарушений | |
| NO20091599L (no) | Kjemiske forbindelser | |
| NO20084924L (no) | N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer | |
| EA200970680A1 (ru) | N-замещенные производные глицина: ингибиторы гидроксилаз | |
| MA35608B1 (fr) | 3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)-amino)éthoxy)phényl)butyl)carbamimidoyl)pyrazine-2-carboxamide | |
| NO20084302L (no) | 2-(syklisk amino)-pyrimidonderivater som TPK1-inhibitorer | |
| EA200970050A1 (ru) | Ингибиторы пролилгидроксилаз | |
| NO20085169L (no) | Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes | |
| TW200801027A (en) | Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids | |
| HK1133596A1 (en) | Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme | |
| NO20091596L (no) | Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer | |
| TW200745066A (en) | Novel PTP1B inhibitors | |
| NO20083535L (no) | Alfa-krystallinsk form av argininsaltet til perindopril, en prosess for dets fremstilling og farmasoytiske sammensetninger inneholdende dette | |
| UA92354C2 (en) | Amino acid salts of rosiglitazone | |
| NO20090136L (no) | Fremgangsmate for fremstilling av salter av N-hydroksy-3-[4-[[[2-(2-metyl-1H-1ln-dol-3-yl)etyl]amino]metyl]fenyl]-2E-2-propenamid | |
| EA200970604A1 (ru) | Новое промежуточное соединение и способ, используемый для получения {2-[1-(3,5-бис-трифторметилбензил)-5-пиридин-4-ил-1н-[1,2,3]триазол-4-ил]пиридин-3-ил}-(2-хлорфенил)метанона | |
| WO2007130821A3 (en) | Mglur5 modulators ii |